Nevro Corp. Stock
Price
Target price
€11.80
€11.80
-
-
-
€31.14
24.04.24 / Stuttgart Stock Exchange
WKN: A12EPL / Symbol: NVRO / Name: Nevro / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Nevro Corp. Stock
Our community is currently high on Nevro Corp. with 4 Buy predictions and 0 Sell predictions.
With a target price of 31 € there is potential for a 162.71% increase which would mean more than doubling the current price of 11.8 € for Nevro Corp..
Pros and Cons of Nevro Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Cons
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Nevro Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Nevro Corp. | - | 1.724% | -5.600% | -60.927% | -40.404% | -91.194% | -78.762% |
| Orasure Tech | 2.410% | 2.049% | -14.138% | -22.791% | -33.154% | -38.412% | -40.622% |
| scPharmaceuticals | 2.830% | 1.435% | -13.115% | -51.818% | -26.261% | -22.909% | - |
| SI-BONE Inc | -2.780% | 1.408% | 2.128% | -27.638% | -24.211% | -49.650% | - |
Comments
Nevro Corp. (NYSE: NVRO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $23.00 price target on the stock.
Show more
Ratings data for NVRO provided by MarketBeat
Nevro Corp. (NYSE: NVRO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $33.00 price target on the stock.
Show more
Ratings data for NVRO provided by MarketBeat
Nevro Corp. (NYSE: NVRO) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $40.00 to $35.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for NVRO provided by MarketBeat
News
Why Nevro Stock Lagged the Market on Thursday
Specialty medical device maker Nevro (NYSE: NVRO) didn't make for an inspiring investment on Thursday. Its stock price dipped marginally following the company's release of its fourth-quarter
